UBS Oncology Impact Fund, Former 10% Owner: Werewolf Therapeutics HOWL Planned sale · Filed 05/18

Trade details

Type: Planned sale notice
Stock: Werewolf Therapeutics HOWL
Person: UBS Oncology Impact FundFormer 10% Owner
Planned sale date: 26/05/18
Filed: 26/05/18

0.5% of shares outstanding to be sold

Werewolf Therapeutics trades, last 26 weeks

What else happened in Werewolf Therapeutics around then

Filed or reported within 30 days of the trade day · 04/18~06/17

UBS Oncology Impact Fund's recent trades

UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$27.3K
80,142 sh
$27.3K
Filed 07/06
Traded 07/06
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$28.4K
87,916 sh
$28.4K
Filed 06/29
Traded 06/29
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$99K
202,029 sh
$99K
Filed 05/28
Traded 05/28
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$47.5K
69,904 sh
$47.5K
Filed 05/11
Traded 05/11
UBS Oncology Impact FundFormer 10% Owner
Planned sale10b5-1 planWerewolf Therapeutics
Planned sale10b5-1 plan
Werewolf Therapeutics
HOWL
$216.5K
300,821 sh
$216.5K
Filed 05/01
Traded 05/01

UBS Oncology Impact Fund, 10% Owner — plans to sell 240,280 sh of Werewolf Therapeutics HOWL · $123.8K · around 05/18 · 10b5-1 plan | Whalegun